Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema.
We retrospectively studied the efficacy of gamma knife surgery (GKS) for metastatic brain tumors from renal cell carcinoma (RCC). To evaluate the efficacy of GKS for control of peritumoral edema, we retrospectively studied 280 consecutive metastatic brain tumors (100 from lung cancers, 100 from breast cancers, and 80 from RCC) associated with peritumoral edema. In addition, this study included 11 patients with metastatic brain tumors from RCC who underwent direct surgery. The tumor growth control rate of GKS was 84.3%. The extent of edema of RCC metastases was significantly larger than those from lung and breast cancer. Primary site (renal or not renal) and delivered marginal dose (25 Gy or more) were significantly correlated with control of peritumoral edema. All tumors treated by direct surgery were more than 2 cm in maximum diameter. Peritumoral edema at surgery was extensive but disappeared within 1-3 months, and neurological symptoms also improved in many cases. Total removal of brain metastases from RCC was easy with little bleeding in most cases. Our results suggest that GKS is effective for growth control of metastatic brain tumors from RCC. Higher marginal dose such as 25 Gy or more is desirable to obtain peritumoral edema control, so GKS is not suitable for control of symptomatic peritumoral edema associated with relatively large tumors. Tumor removal of RCC metastases is relatively easy and rapidly reduces peritumoral edema. Treatment strategy for metastatic brain tumors from RCC depends on tumor size, number of tumors, and presence of symptomatic peritumoral edema.
Shuto
Takashi
T
Department of Neurosurgery, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kouhoku-ku, Yokohama, Kanagawa, 222-0036, Japan. shuto@yokohamah.rofuku.go.jp
Matsunaga
Shigeo
S
Suenaga
Jun
J
Inomori
Shigeo
S
Fujino
Hideyo
H
D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D002292:Carcinoma, Renal Cell / Q000473:pathology*; D003399:Craniotomy / Q000379:methods*; D004487:Edema / Q000209:etiology / Q000601:surgery; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D016634:Radiosurgery / Q000379:methods*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
Int J Radiat Oncol Biol Phys. 1992;24(4):619-25
1429083
N Engl J Med. 1990 Feb 22;322(8):494-500
2405271
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):253-8
14697446
Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):2007-9
2414257
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1389-93
11121638
Minim Invasive Neurosurg. 2004 Aug;47(4):203-8
15346315
Anticancer Res. 2007 Nov-Dec;27(6C):4255-7
18214028
J Neurosurg. 2000 Dec;93 Suppl 3:32-6
11143259
Cancer. 1983 Feb 15;51(4):614-7
6185207
Cancer. 1998 Jul 15;83(2):344-53
9669818
Cancer. 1981 Sep 15;48(6):1487-91
7272969
Cancer J. 2000 Nov-Dec;6(6):372-6
11131486
Acta Neurochir (Wien). 2003 Sep;145(9):755-60
14505101
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1279-83
12128130
Int J Urol. 2002 Nov;9(11):618-25; discussion 626; author reply 627
12534903
J Neurosurg. 2002 Dec;97(5 Suppl):489-93
12507083
J Neurosurg. 1993 Aug;79(2):210-6
8331402
J Neurosurg. 2002 Oct;97(4):785-93
12405364
J Neurosurg. 2006 Oct;105(4):555-60
17044558
J Neurosurg. 2003 Feb;98(2):342-9
12593621
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1061-5
18245140
J Neurooncol. 2009 Jan;91(1):47-50
18712279
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1007-12
10863072
Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):797-802
8138431
Acta Neurochir (Wien). 1998;140(6):549-55
9755321
Stereotact Funct Neurosurg. 1998 Oct;70 Suppl 1:41-9
9782234
Urol Oncol. 2004 Jan-Feb;22(1):25-31
14969800
Acta Neurochir (Wien). 2004 Sep;146(9):989-93; discussion 993
15340810
Cancer. 1986 Aug 1;58(3):641-9
3731022
Neurosurgery. 2002 Sep;51(3):656-65; discussion 665-7
12188943
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1543-8
19135317